A carregar...
Pyrotinib Sensitizes 5-Fluorouracil-Resistant HER2(+) Breast Cancer Cells to 5-Fluorouracil
5-Fluorouracil (5-FU) is a widely used chemotherapeutic agent for breast cancer. However, acquired chemoresistance leads to a loss of its efficacy; methods to reverse are urgently needed. Some studies have shown that pyrotinib, an ErbB receptor tyrosine kinase inhibitor, is effective against HER2(+)...
Na minha lista:
| Publicado no: | Oncol Res |
|---|---|
| Main Authors: | , , , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Cognizant Communication Corporation
2020
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7751227/ https://ncbi.nlm.nih.gov/pubmed/32727638 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3727/096504020X15960154585410 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|